Repligen Corporation ( RGEN) - Stock Earnings
RGEN Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 3, 2026, midnight | — / — | — | — / — | — |
RGEN Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 13.3 million USD | 197.9 million USD |
| 2026Q1 | 8.3 million USD | 194.3 million USD |
| 2026Q2 | 5.0 million USD | 204.1 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
RGEN Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 41.6 million USD | 638.8 million USD |
| 2024 | -25.5 million USD | 634.4 million USD |
| 2025 | 48.9 million USD | 738.3 million USD |
| 2026 Est. | — | — |
RGEN
Price: $178.20
Earnings Per Share: 0.73 USD
P/E Ratio: 201.45
Exchange: NMS
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: United States
Volume: 633600
Ebitda: 2.7 millionMarket Capitalization: 9.4 billion